A mixture of 20 strains of lactic acid-producing probiotic bacteria was able to mitigate the hepatic inflammation and subsequent NAFLD progression to fibrosis and HCC in a phosphate and tensin homolog (PTEN) gene knockout mouse model [160]. The gene discussed is PTEN; the disease is metabolic dysfunction-associated steatotic liver disease.